Jean Coutu Group PJC (TSE: PJC.A) has recently received a number of price target changes and ratings updates:

  • 7/12/2017 – Jean Coutu Group PJC had its price target lowered by analysts at National Bank Financial from C$23.00 to C$21.00.
  • 7/12/2017 – Jean Coutu Group PJC had its price target raised by analysts at TD Securities from C$20.00 to C$21.00. They now have a “hold” rating on the stock.
  • 7/6/2017 – Jean Coutu Group PJC had its price target lowered by analysts at Eight Capital from C$23.00 to C$21.00.
  • 7/5/2017 – Jean Coutu Group PJC had its price target lowered by analysts at Barclays PLC from C$19.00 to C$17.00. They now have an “underweight” rating on the stock.
  • 7/4/2017 – Jean Coutu Group PJC had its price target lowered by analysts at Royal Bank Of Canada from C$20.00 to C$19.00. They now have an “underperform” rating on the stock.
  • 6/29/2017 – Jean Coutu Group PJC had its price target lowered by analysts at National Bank Financial from C$25.00 to C$24.00.
  • 5/24/2017 – Jean Coutu Group PJC was upgraded by analysts at Desjardins from a “sell” rating to a “hold” rating. They now have a C$21.00 price target on the stock, up previously from C$20.00.

The Jean Coutu Group (PJC) Inc is a Canada-based company, which is engaged in franchising pharmacy chains. The Company operates through two segments: franchising and generic drugs. Within the franchising segment, the Company carries on the franchising activity under the banners of PJC Jean Coutu, PJC Clinique, PJC Jean Coutu Sante and PJC Jean Coutu Sante Beaute; operates approximately two distribution centers, and coordinates various other services for its franchisees.

Receive News & Ratings for Jean Coutu Group PJC Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jean Coutu Group PJC Inc and related companies with MarketBeat.com's FREE daily email newsletter.